CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 304 enrolled
Drug / intervention
Meperidine, Midazolam +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00937924
NCT00937924Phase 4Completed
CompareCT.gov

A Randomized, Double-Blinded, Placebo-Controlled Trial of Promethazine and Diphenhydramine as Adjunct Sedatives for Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP)

University of California, Irvine·interventional·Posted Jul 13, 2009·Updated Feb 26, 2024

In Brief

A Phase 4 clinical trial evaluating Meperidine, Midazolam, Diphenhydramine, and 1 other intervention for Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP). Completed, enrolled 304 participants across 1 site.

Detailed Summary

The purpose of this study is to compare meperidine/midazolam with diphenhydramine, meperidine/midazolam with promethazine, and meperidine/midazolam with placebo as sedation methods. The investigators are interested to see whether adjunct sedatives (diphenhydramine and promethazine) will improve sedation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndoscopic Ultrasound (EUS), Endoscopic Retrograde Cholangiopancreatography (ERCP)
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 13, 2009
Enrollment StartFeb 1, 2008
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 17.0 years ago

Interventions

Meperidine, Midazolamdrug

Diphenhydraminedrug

Promethazinedrug